Board of Directors
Henrik Gürtler, Member of the board
Henrik Gürtler has been president and CEO of Novo A/S, Denmark, since 2000. He was employed by Novo Industri A/S, Denmark, as an R&D chemist in the Enzymes Division in 1977. After a number of years in various specialist and managerial positions within this area, Mr Gürtler was appointed corporate vice president of Human Resource Development in Novo Nordisk A/S in 1991, and in 1993 he was appointed corporate vice president of Health Care Production. From 1996 to 2000 he was a member of Corporate Management of Novo Nordisk A/S with special responsibility for Corporate Staffs.
Mr Gürtler is chairman of the boards of Novozymes A/S and Copenhagen Airports A/S, both in Denmark. Mr Gürtler has an MSc in Chemical Engineering from the Technical University of Denmark from 1976.
Mr Gürtler was first elected to the Board of Novo Nordisk A/S in 2005 and has been re-elected several times, most recently in 2013. His term as a board member expires in March 2014.
In March 2013, the Board of Directors of Novo Nordisk A/S assessed that Mr Gürtler is not regarded as an independent board member as defined in Section 5.4.1 of the Recommendations on Corporate Governance designated by NASDAQ OMX Copenhagen (2011) due to his position as president and CEO of Novo A/S.
In January 2013, the Board of Directors assessed that the special competences possessed by Mr Gürtler that are important for the performance of his duties are his knowledge of the Novo Group’s business and its policies and his knowledge of the international biotech industry.
Mr Gürtler is a male Danish national, born August 1953.